down arrow

Parmax Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE240T01014
  • NSEID:
  • BSEID: 540359
INR
39.00
-5.7 (-12.75%)
BSENSE

Apr 11, 12:52 PM

BSE+NSE Vol: 18

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Parmax Pharma Ltd stock-summary
stock-summary
Parmax Pharma Ltd
Micro Cap
Pharmaceuticals & Drugs
Incorporated in Nov.'94, Parmax Pharma Ltd (PPL) was promoted by Jayantilal S Dhol, Purushottam J Bhalodi and Prabhudas D Hansalpara. The Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations ( CMO) business are the key pillar of Parmax's pharmaceutical operations. The Promoters were earlier into manufacturing of bulk drugs like Ampicilin, Amoxycillin, Cephalexin, Nalidixic Acid etc.
Company Coordinates stock-summary
Company Details
Plot No 20 Survey No 52, Tal Kotda Sangani Hadamtala Rajkot Gujarat : 360311
stock-summary
Tel: 91-2827-270534/535
stock-summary
http://www.parmaxpharma.com
stock-summary
info@parmaxpharma.com
Registrar Details
Purva Shareregistry (India) Pvt Ltd , Gala No 9, Shiv Shakti, Industrial Estate,Sitaram Mill Comp., J R Boricha Marg, Lower Parel [E], Mumbai
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 3.74 Cr
Number of Shares
37.41 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
15-Mar-2017
37.41
3.74
3741300
10
Allotment of Equity To Others
15-Mar-2017
37.41
3.74
3741300
10
Allotment of Equity To Others
23-Mar-2016
37.41
3.74
-1359500
10
Forfeited Shares
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Alkesh Mahasukh Gopani (17.92%)

Highest Public shareholder

Gosalia Meena Alkesh (12.69%)

Individual Investors Holdings

63.12%

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
Umang Alkesh Gosalia
Managing Director
34.2 lacs
Pramay Amritlal Chhatra
Non-Exec. & Independent Dir.
0
Ami R Shah
Non-Exec. & Independent Dir.
0
Yash Vora
Company Sec. & Compli. Officer
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
Raw Material Consumed
3.92331
0%
 
100
Raw Material Consumed
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Labour Job Work
4.01
33.73%
 
33.73
Labour Job Work
66.27
Labour Job Work
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
6 Cr
(Quarterly Results - Dec 2024)
Net Profit:
0 Cr
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 14 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

5.86

stock-summary
Return on Equity

-205.00%

stock-summary
Price to Book

16.72

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."